Carisma Therapeutics, Inc. Share Price & Technical Analysis
CARM · $0.00
Healthcare / Biotechnology
$0.00
Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, which is in preclinical trial for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced …
Price chart
Seasonality
May has 1 positive and 1 negative years (last 3 years shown)
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25 | 25% | 0% | -25% | -33% | 0% | 100% | -25% | -33% | -40% | -67% | 0% | – | -98% |
| 24 | -28% | 24% | -12% | -30% | -19% | 15% | -27% | 0% | 0% | 0% | -10% | -56% | -141% |
| 23 | – | – | -47% | 31% | 36% | 52% | -36% | 25% | -40% | -29% | -20% | 21% | -7% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, which is in preclinical trial for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothelioma, and others. In addition, it develops in vivo CAR-M cell therapy to treat solid tumors, including hepatocellular carcinoma. Carisma Therapeutics, Inc. has collaboration and license agreement with ModernaTX, Inc. to address oncology gene therapies. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. Carisma Therapeutics, Inc. was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$8.37K
P/E ratio
0
52W high
$1.27
52W low
$0.00
Volume
10,296
Beta
1.31
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Carisma Therapeutics, Inc. share price today?
- Carisma Therapeutics, Inc. (CARM) last traded around $0.00 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CARM have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CARM. Download the app for real-time alerts.
- How can I analyze Carisma Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.